Last reviewed · How we verify

NCT07324954

Methylene Blue in Total Knee Arthroplasty (TKA)

Recruiting now Phase 1 Last updated 14 April 2026
What this trial tests

Phase 1 trial testing Methylene Blue 10 MG/ML (intra-articular application) in Total Knee Arthroplasty in 20 participants. Currently enrolling.

Timeline
4 February 2026
Primary endpoint
1 February 2027
1 February 2027

Quick facts

Lead sponsorUniversity of Miami
PhasePhase 1
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment20
Start date4 February 2026
Primary completion1 February 2027
Estimated completion1 February 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

18 and older, any sex, with Total Knee Arthroplasty or Prosthetic-joint Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pilot study is to determine the volume of irrigation required to achieve macroscopic clearance of contaminants during a debridement, antibiotics, and implant retention (DAIR) procedure for periprosthetic joint infection (PJI) of the knee. Given the lack of robust data guiding irrigation volume in this setting, the investigator proposes to use the application of methylene blue dye intraoperatively to simulate contaminant presence. Serial irrigation will be performed, with photographic documentation taken every 2,000mL until visible dye clearance is achieved. This study aims to identify the irrigation volumes that result in gross clearance of simulated contamination, thereby informing the design and stratification of a future randomized controlled trial (RCT) evaluating irrigation strategies in DAIR procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Total Knee Arthroplasty

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07324954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing